WallStreetZenWallStreetZen

NASDAQ: AMRX
Amneal Pharmaceuticals Inc Stock Ownership - Who owns Amneal Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Amneal Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ted C. NarkDirector2025-11-1750,000$11.72
$586.00kSell
Nikita ShahExecutive Vice President2025-11-1295,525$2.75
$262.69kBuy
Nikita ShahExecutive Vice President2025-11-12131,856$11.92
$1.57MSell
Nikita ShahExecutive Vice President2025-11-1236,331$2.75
$99.91kBuy
John KielyDirector2025-08-2732,000$9.23
$295.36kSell
Nikita ShahExecutive Vice President2025-08-256,340$9.50
$60.23kSell
Nikita ShahExecutive Vice President2025-08-22114,492$9.66
$1.11MSell
Andrew S. BoyerExecutive Vice President2025-08-20175,000$2.75
$481.25kBuy
Andrew S. BoyerExecutive Vice President2025-08-20279,244$9.38
$2.62MSell
Tasos KonidarisExecutive Vice President CFO2025-08-15219,159$9.43
$2.07MSell

1 of 6

AMRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AMRX insiders and whales buy or sell their stock.

AMRX Shareholders

What type of owners hold Amneal Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Tushar Bhikhubhai Patel49.54%155,734,627$1.90BInsider
Gautam Patel15.25%47,954,644$585.53MInsider
Dipan Patel8.56%26,905,073$328.51MInsider
Dipan 1. Patel8.56%26,905,073$328.51MInsider
Chintu Patel8.15%25,617,285$312.79MInsider
Chirag K. Patel7.04%22,127,400$270.18MInsider
Fosun International Ltd5.86%18,407,656$224.76MInsider
Vanguard Group Inc5.71%17,954,973$219.23MInstitution
Ambient Impact Hk Ltd5.23%16,438,356$200.71MInsider
Tpg Group Holdings Sbs Advisors Inc5.16%16,213,367$197.97MInsider

1 of 3

AMRX vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AMRX28.65%71.35%Net SellingNet Selling
LNTH51.58%48.42%Net Selling
INDV100.00%0.00%
PBH68.85%31.15%Net SellingNet Selling
ALKS93.24%6.76%Net SellingNet Selling
View Top Pharmaceutical Stocks

Amneal Pharmaceuticals Stock Ownership FAQ

Who owns Amneal Pharmaceuticals?

Amneal Pharmaceuticals (NASDAQ: AMRX) is owned by 47.57% institutional shareholders, 118.47% Amneal Pharmaceuticals insiders, and 0.00% retail investors. Tushar Bhikhubhai Patel is the largest individual Amneal Pharmaceuticals shareholder, owning 155.73M shares representing 49.54% of the company. Tushar Bhikhubhai Patel's Amneal Pharmaceuticals shares are currently valued at $1.91B.

If you're new to stock investing, here's how to buy Amneal Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.